Mizagliflozin
2,2-dimethyl-3-[3-[3-methyl-4-[[5-propan-2-yl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-pyrazol-4-yl]methyl]phenoxy]propylamino]propanamide
Molecular Identity
Mizagliflozin
2,2-dimethyl-3-[3-[3-methyl-4-[[5-propan-2-yl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-pyrazol-4-yl]methyl]phenoxy]propylamino]propanamide
PubChem CID: 10460535
2D Structure
Properties
C28H44N4O8
Molecular Formula
564.70
Molecular Weight
g/mol
564.3159
Exact Mass
Da
1.5
XLogP
Drug-like (Lipinski: < 5)
192
TPSA
May have limited oral absorption
7
H-Bond Donors
10
H-Bond Acceptors
789
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Mizagliflozin666843-10-31X96A704XVDSP-3235KGA-32353-((3-(4-((3-(beta-D-Glucopyranosyloxy)-5-(propan-2-yl)-1H-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethylpropanamidePropanamide, 3-((3-(4-((3-(beta-D-glucopyranosyloxy)-5-(1-methylethyl)-1H-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethyl-mizagliflozinamizagliflozinemizagliflozinum2,2-dimethyl-3-(3-(3-methyl-4-((3-propan-2-yl-5-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-2H-pyrazol-4-yl)methyl)phenoxy)propylamino)propanamide2,2-dimethyl-3-[3-[3-methyl-4-[[3-propan-2-yl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2H-pyrazol-4-yl]methyl]phenoxy]propylamino]propanamideRefChem:159145Mizagliflozin [INN]Mizagliflozin [WHO-DD]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Mizagliflozin
Loading drug network...